Publication Cover
Reproductive Health Matters
An international journal on sexual and reproductive health and rights
Volume 22, 2014 - Issue sup44: Expanding access to medical abortion
4,463
Views
23
CrossRef citations to date
0
Altmetric
Original Research Articles

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City

, , , , , , & show all

References

  • J Blum, S Raghavan, R Dabash. Comparison of misoprostol-only and combined mifepristone–misoprostol regimens for home-based early medical abortion in Tunisia and Vietnam. International Journal of Gynecology & Obstetrics. 118: 2012; 166–171. 10.1016/j.ijgo.2012.03.039.
  • B Winikoff, IG Dzuba, MD Creinin. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial. Obstetrics & Gynecology. 112: 2008; 1303–1310. 10.1097/AOG.0b013e31818d8eb4.
  • P Goldstone, J Michelson, E Williamson. Early medical abortion using low-dose mifepristone followed by buccal misoprostol: a large Australian observational study. Medical Journal of Australia. 197: 2012; 282–286.
  • S Raghavan, T Tsereteli, A Kamilov. Acceptability and feasibility of the use of 400 μg of sublingual misoprostol after mifepristone for medical abortion up to 63 days since the last menstrual period: evidence from Uzbekistan. European Journal of Contraception and Reproductive Health Care. 18: 2013; 104–111. 10.3109/13625187.2013.763225.
  • H von Hertzen, NT Huong, G Piaggio, WHO Research Group on Postovulatory Methods of Fertility Regulation. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial. BJOG. 117: 2010; 1186–1196. 10.1111/j.1471-0528.2010.02636.x.
  • M Peña, IG Dzuba, P Sanhueza Smith. Efficacy and acceptability of a mifepristone–misoprostol combined regimen for early induced abortion among women in Mexico City. International Journal of Gynecology & Obstetrics. 127: 2014; 82–85. 10.1016/j.ijgo.2014.04.012.
  • World Health Organization. Safe Abortion: Technical and Policy Guidance for Health Systems. 2nd ed., 2012; WHO: Geneva. http://apps.who.int/iris/bitstream/10665/70914/1/9789241548434_eng.pdf.
  • D Becker, C Díaz Olavarrieta. Decriminalization of abortion in Mexico City: The effects on women’s reproductive rights. American Journal of Public Health. 103: 2013; 590–593.
  • Secretariat of Health of Mexico City. Information system of the Legal Termination of Pregnancy Program. Provisional data, June 2014.
  • M Mondragón y Kalb, A Ahued Ortega, J Morales Velazquez. Patient characteristics and service trends following abortion legalization in Mexico City, 2007–10. Studies in Family Planning. 42: 2011; 159–166.
  • B Winikoff, IG Dzuba, E Chong. Extending outpatient medical abortion services through 70 days of gestational age. Obstetrics & Gynecology. 120: 2012; 1070–1076. Doi: http://10.1097/AOG.0b013e31826c315f.
  • National Abortion Federation. 2014 Clinical Policy Guidelines. 2014; NAF: Washington, DC. http://prochoice.org/education-and-advocacy/2014-clinical-policy-guidelines/.
  • H Bracken, R Dabash, G Tsertsvadze. A two-pill sublingual misoprostol outpatient regimen following mifepristone for medical abortion through 70 days LMP: a prospective comparative open-label trial. Contraception. 89: 2014; 181–186. 10.1016/j.contraception.2013.10.018.
  • AA Boersma, B Meyboom-de Jong, G Kleiverda. Mifepristone followed by home administration of buccal misoprostol for medical abortion up to 70 days of amenorrhoea in a general practice in Curaçao. European Journal of Contraception and Reproductive Health Care. 16: 2011; 61–66. 10.3109/13625187.2011.555568.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.